To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
Impact
The bill's limitations could significantly impact the National Institute on Drug Abuse’s ability to allocate resources for various programs aimed at combatting addiction and supporting research in drug-related issues. By capping the funding, it may hinder efforts to respond effectively to the ongoing drug epidemic. Supporters of the bill likely argue that it provides necessary fiscal restraint and encourages more efficient use of taxpayer dollars, whereas critics may view it as a detrimental cut to essential health services aimed at reducing drug abuse and its societal impacts.
Summary
House Bill 1990 aims to impose a limitation on the availability of funds for the Department of Health and Human Services, specifically targeting the National Institute on Drug Abuse for the fiscal year 2024. The bill stipulates that the amount appropriated for this purpose shall not exceed $1,419,844,000. This legislative measure is introduced amid ongoing discourse regarding the adequacy of funding levels for drug abuse initiatives and reflects the priorities of certain lawmakers in addressing health-related funding concerns.
Contention
Debate surrounding HB1990 is likely to center on the balance between fiscal responsibility and public health priorities. Proponents may argue that controlling funding will help curb wasteful spending, while opponents could express concerns that the reduced financial commitment to the National Institute on Drug Abuse could lead to inadequate responses to the growing addiction crisis. This ideological divide emphasizes the broader tensions between budgetary constraints and the urgent need for comprehensive health interventions.
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
No Pro-Abortion Task Force Act This bill prohibits federal funding of the Reproductive Healthcare Access Task Force. The Department of Health and Human Services launched the task force on January 21, 2022, to identify and coordinate departmental activities related to accessing sexual and reproductive health care.
World Deserves To Know Act This bill requires sanctions on certain members of the Chinese Communist Party (CCP) and officials of Chinese health agencies. It also addresses related issues. The President must impose visa- and property-blocking sanctions on any foreign person who is a CCP official and who is knowingly responsible for or complicit in (1) the disappearances of whistleblowers and citizen journalists in China relating to COVID-19, or (2) limiting free speech and academic freedom in China relating to COVID-19. The President must also impose such sanctions on specified individuals who have leadership positions in China's Center for Disease Control and Prevention and China's National Health Commission (NHC). The authority to impose such sanctions shall end when the President certifies to Congress that an independent and unimpeded investigation into the potential origin of COVID-19 from the Wuhan Institute of Virology has taken place. The bill also bars federal funds and certain federal student assistance from going to institutions of higher education that enter into a contract with any element or China-based affiliate of the NHC. Federal funding to the National Academy of Sciences may not be used to enter into a contract with any element or China-based affiliate of the NHC. The Government Accountability Office must report to Congress a review of all funds that the National Institutes of Health have made available to the NHC since FY2010. This report must also be publicly available.
Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
Appropriations: department of health and human services; appropriations for fiscal year 2026-2027 for human services; provide for. Creates appropriation act.
This bill grants exclusive jurisdiction to the U.S. District Court for the District of Columbia over (1) cases arising under immigration laws, or (2) claims by foreign nationals challenging an order of removal or another action authorized under the Immigration and Nationality Act.